Related Experiment Video
Updated: Jan 19, 2026
Measuring Statistical Learning Across Modalities and Domains in School-Aged Children Via an Online Platform and Neuroimaging Techniques
Published on: June 30, 2020
ADPedKD: A Global Online Platform on the Management of Children With ADPKD
Stéphanie De Rechter1,2, Detlef Bockenhauer3,4, Lisa M Guay-Woodford5
1Department of Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) in children is increasingly recognized, yet management guidelines are lacking. The global ADPedKD project establishes a large international pediatric ADPKD cohort to gather crucial data for improved care.
Area of Science:
- Nephrology
- Genetics
- Pediatric Medicine
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a leading monogenic cause of kidney failure, historically viewed as an adult-onset condition.
- Recent understanding highlights that ADPKD often begins in childhood, necessitating specific pediatric management strategies.
- Current evidence-based guidelines and risk stratification tools for pediatric ADPKD are insufficient, creating a critical knowledge gap.
Purpose of the Study:
- To establish the most extensive international cohort of children diagnosed with ADPKD.
- To deeply characterize the disease's clinical course and genetic factors in pediatric patients.
- To lay the groundwork for developing unified diagnostic and treatment recommendations for childhood ADPKD.
Main Methods:
- The Global ADPedKD project is an international, multicenter, observational study.
- Data is collected through interoperable, web-based databases across seven global chapters.
- A detailed questionnaire and longitudinal follow-up capture retrospective and prospective clinical, radiological, and laboratory data, including genetics and therapeutic interventions.
Main Results:
- The ADPedKD project has initiated the formation of a large international pediatric ADPKD cohort.
- The study is collecting comprehensive data on clinical, radiological, and laboratory findings, as well as genetic information and treatment interventions.
- This data collection is designed to provide deep characterization of the disease in children.
Conclusions:
- The global ADPedKD initiative is creating the most extensive pediatric ADPKD cohort to date.
- The collected evidence will support the development of unified recommendations for diagnosis, follow-up, and treatment of modifiable disease factors in pediatric ADPKD.
- This registry will serve as a platform for identifying biomarkers to predict early and progressive disease risk in children.
Background:
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the past decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at risk of ADPKD are lacking. Also, scoring systems to stratify patients into risk categories have been established only for adults. Overall, there are insufficient data on the clinical course during childhood. We therefore initiated the global ADPedKD project to establish a large international pediatric ADPKD cohort for deep characterization.
Methods:
Global ADPedKD is an international multicenter observational study focusing on childhood-diagnosed ADPKD. This collaborative project is based on interoperable Web-based databases, comprising 7 regional and independent but uniformly organized chapters, namely Africa, Asia, Australia, Europe, North America, South America, and the United Kingdom. In the database, a detailed basic data questionnaire, including genetics, is used in combination with data entry from follow-up visits, to provide both retrospective and prospective longitudinal data on clinical, radiologic, and laboratory findings, as well as therapeutic interventions.
Discussion:
The global ADPedKD initiative aims to characterize in detail the most extensive international pediatric ADPKD cohort reported to date, providing evidence for the development of unified diagnostic, follow-up, and treatment recommendations regarding modifiable disease factors. Moreover, this registry will serve as a platform for the development of clinical and/or biochemical markers predicting the risk of early and progressive disease.
More Related Videos
Related Concept Videos
08:05Measuring Statistical Learning Across Modalities and Domains in School-Aged Children Via an Online Platform and Neuroimaging Techniques
13:14Global Gene Expression Analysis Using a Zebrafish Oligonucleotide Microarray Platform
01:50Global Climate Change
08:55Online Transcranial Magnetic Stimulation Protocol for Measuring Cortical Physiology Associated with Response Inhibition
09:44Methods to Test Visual Attention Online
07:29Online Explorative Study on the Learning Uses of Virtual Reality Among Early Adopters